Holen Sie sich die Stockscreener-App
1.45
3.33%
-0.05
Schlusskurs vom Vortag:
$1.50
Offen:
$1.5
24-Stunden-Volumen:
550.27K
Relative Volume:
0.44
Marktkapitalisierung:
$234.82M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-274.18M
KGV:
-0.5721
EPS:
-2.5346
Netto-Cashflow:
$-198.33M
1W Leistung:
-11.04%
1M Leistung:
-11.04%
6M Leistung:
+21.85%
1J Leistung:
-87.64%
1-Tages-Spanne:
$1.42
$1.585
1-Wochen-Bereich:
$1.42
$1.67
52-Wochen-Spanne:
$0.611
$17.19
Neumora Therapeutics Inc Stock (NMRA) Company Profile
Firmenname
Neumora Therapeutics Inc
Sektor
Branche
Telefon
(857) 760-0900
Adresse
260 ARSENAL PLACE, SUITE 1, WATERTOWN
Vergleichen Sie NMRA mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
NMRA
Neumora Therapeutics Inc
|
1.45 | 242.92M | 0 | -274.18M | -198.33M | -2.5346 |
|
VRTX
Vertex Pharmaceuticals Inc
|
387.15 | 100.34B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
585.50 | 60.95B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
451.73 | 60.46B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
734.35 | 46.04B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
332.20 | 36.02B | 3.81B | -644.79M | -669.77M | -6.24 |
Neumora Therapeutics Inc Stock (NMRA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-04-02 | Herabstufung | BofA Securities | Buy → Underperform |
| 2025-03-10 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2025-03-07 | Herabstufung | Guggenheim | Buy → Neutral |
| 2025-03-07 | Herabstufung | Stifel | Buy → Hold |
| 2025-01-02 | Herabstufung | RBC Capital Mkts | Outperform → Sector Perform |
| 2024-11-05 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2024-10-01 | Eingeleitet | H.C. Wainwright | Buy |
| 2024-07-22 | Eingeleitet | Needham | Buy |
| 2024-07-08 | Eingeleitet | Mizuho | Outperform |
| 2023-12-12 | Eingeleitet | Deutsche Bank | Hold |
| 2023-10-10 | Eingeleitet | BofA Securities | Buy |
| 2023-10-10 | Eingeleitet | Guggenheim | Buy |
| 2023-10-10 | Eingeleitet | JP Morgan | Overweight |
| 2023-10-10 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2023-10-10 | Eingeleitet | Stifel | Buy |
| 2023-10-10 | Eingeleitet | William Blair | Outperform |
Alle ansehen
Neumora Therapeutics Inc Aktie (NMRA) Neueste Nachrichten
Neumora Therapeutics (NASDAQ:NMRA) Cut to Underweight at JPMorgan Chase & Co. - MarketBeat
Bearish Setup: Is Neumora Therapeutics Inc. part of any major index2025 Analyst Calls & Smart Investment Allocation Tips - خودرو بانک
Neumora Therapeutics downgraded to Underweight from Neutral at JPMorgan - TipRanks
Published on: 2025-09-16 19:41:45 - خودرو بانک
JPM downgrades Neumora, cites risk of more negative trial news - Investing.com
Buyout Rumor: Will Upstream Bio Inc outperform during market rallies2025 Growth vs Value & Accurate Intraday Trading Signals - خودرو بانک
JPMorgan Downgrades Neumora Therapeutics to Underweight From Neutral - MarketScreener
J.P.Morgan downgrades Neumora, citing challenges in depression drug development - TradingView
Panic Selling: What is Neumora Therapeutics Incs 5 year growth outlook2025 Buyback Activity & Accurate Trade Setup Notifications - خودرو بانک
aTyr pharma, Clear Secure, Neumora Therapeutics - TradingView
Guidance Update: Will Neumora Therapeutics Inc. benefit from geopolitical trendsForecast Cut & High Accuracy Swing Entry Alerts - خودرو بانک
Trade Report: How does Neumora Therapeutics Inc perform in inflationary periods2025 Price Targets & Growth Focused Investment Plans - خودرو بانک
Stock Market Recap: What is Neumora Therapeutics Incs 5 year growth outlook2025 Trading Volume Trends & Long-Term Capital Growth Strategies - خودرو بانک
Published on: 2025-09-15 12:35:55 - خودرو بانک
Breakout Watch: Is Neumora Therapeutics Inc showing insider buyingJuly 2025 Big Picture & Community Verified Trade Signals - خودرو بانک
Neumora Therapeutics, Inc. (NASDAQ:NMRA) Short Interest Down 26.3% in August - MarketBeat
Brokerages Set Neumora Therapeutics, Inc. (NASDAQ:NMRA) PT at $7.14 - MarketBeat
220,970 Shares in Neumora Therapeutics, Inc. $NMRA Acquired by Nuveen LLC - MarketBeat
Neumora Therapeutics, Inc. $NMRA Shares Purchased by Graham Capital Management L.P. - MarketBeat
Rate Hike: What’s the MACD signal for Neumora Therapeutics Inc.2025 Earnings Surprises & Low Risk Profit Maximizing Plans - classian.co.kr
How does Neumora Therapeutics Inc. perform in inflationary periodsJuly 2025 Trends & Technical Pattern Based Signals - 뉴스영
Neumora Therapeutics Inc. stock trend outlook and recovery pathMarket Growth Review & Low Drawdown Investment Ideas - Newser
What MACD signals say about Neumora Therapeutics Inc.Dividend Hike & Real-Time Stock Movement Alerts - Newser
Can momentum traders help lift Neumora Therapeutics Inc.Weekly Trading Summary & Verified Momentum Watchlists - Newser
Published on: 2025-09-06 04:28:35 - Newser
Can Neumora Therapeutics Inc. stock double in the next yearJuly 2025 WrapUp & Daily Profit Focused Screening - خودرو بانک
FOMO Trade: Will Neumora Therapeutics Inc. stock go up in YEARAnalyst Upgrade & Fast Gaining Stock Strategy Reports - خودرو بانک
Can Neumora Therapeutics Inc. outperform in the next rallyJuly 2025 Retail & Low Drawdown Momentum Ideas - خودرو بانک
What are Neumora Therapeutics Inc.’s earnings expectationsForecast Cut & High Yield Stock Recommendations - خودرو بانک
Can trapped investors hope for a rebound in Neumora Therapeutics Inc.Market Volume Summary & Real-Time Volume Triggers - Newser
What are the future prospects of Neumora Therapeutics Inc.July 2025 Market Mood & Growth Focused Entry Point Reports - خودرو بانک
Using RSI to spot recovery in Neumora Therapeutics Inc.2025 Trading Volume Trends & Fast Moving Market Watchlists - Newser
What machine learning models say about Neumora Therapeutics Inc.July 2025 Snapshot & AI Enhanced Market Trend Forecasts - Newser
Can swing trading help recover from Neumora Therapeutics Inc. lossesTrade Risk Assessment & Community Verified Trade Signals - Newser
What the charts say about Neumora Therapeutics Inc. today2025 Pullback Review & High Accuracy Trade Signal Alerts - Newser
Will a bounce in Neumora Therapeutics Inc. offer an exitGap Up & Fast Entry Momentum Trade Alerts - Newser
What is the long term forecast for Neumora Therapeutics Inc. stock - خودرو بانک
Published on: 2025-09-05 04:04:09 - خودرو بانک
Block Trades: Is now the right time to enter Neumora Therapeutics Inc.2025 Winners & Losers & Community Consensus Trade Signals - خودرو بانک
Published on: 2025-09-04 17:51:19 - خودرو بانک
Published on: 2025-09-04 05:04:03 - Newser
How to forecast Neumora Therapeutics Inc. trends using time series2025 Technical Overview & Free Weekly Watchlist of Top Performers - Newser
Momentum divergence signals in Neumora Therapeutics Inc. chartTrade Exit Summary & AI Forecast for Swing Trade Picks - Newser
What data driven models say about Neumora Therapeutics Inc.’s futureWeekly Trend Summary & Consistent Growth Equity Picks - Newser
Can Neumora Therapeutics Inc. sustain its profitabilityTrade Exit Summary & Daily Chart Pattern Signals - خودرو بانک
Has Neumora Therapeutics Inc. formed a bullish divergenceTrade Entry Report & High Accuracy Trade Alerts - Newser
Why Neumora Therapeutics Inc. is moving todayJuly 2025 Short Interest & AI Based Buy and Sell Signals - Newser
Can trapped investors hope for a rebound in Neumora Therapeutics Inc2025 Dividend Review & Fast Gaining Stock Strategy Reports - Newser
Custom watchlist performance reports with Neumora Therapeutics Inc.Quarterly Profit Review & Long-Term Capital Growth Strategies - Newser
Will Neumora Therapeutics Inc. benefit from sector rotationPortfolio Growth Summary & Risk Adjusted Swing Trade Ideas - خودرو بانک
Applying big data sentiment scoring on Neumora Therapeutics Inc.Dip Buying & Advanced Swing Trade Entry Alerts - Newser
Finanzdaten der Neumora Therapeutics Inc-Aktie (NMRA)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.62%
0.57%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):